Pregled bibliografske jedinice broj: 215570
Vaccination status in CF patients
Vaccination status in CF patients // Journal of cystic fibrosis, 2 (2003), Suppl 1; S99-S112 (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)
CROSBI ID: 215570 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Vaccination status in CF patients
Autori
Tješić-Drinković, Dorian, Tješić-Drinković, Duška ; Votava-Raić, Ana ; Kelečić, Jadranka ; Voskresensky-Baričić, Tamara
Izvornik
Journal of cystic fibrosis (1569-1993) 2
(2003), Suppl 1;
S99-S112
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kongresno priopcenje, znanstveni
Ključne riječi
Vaccination; cystic fibrosis
Sažetak
Bacterial and viral infections, especially in early life, can trigger pulmonary disease progression in CF patients. The aim of this study was to analyze the vaccination status in Croatian CF patients. Data were collected from 30 CF patients (1/3 of the recognized CF population: 12 boys and 28 girls, aged 6mo to 25yr, median age: 6yr ; genotype: 25 dF508/dF508, 5 heterozygots dF508). Croatia’ s national immunization program covers BCG, DTP, Polio and MMR in the first 18mo of life. Hep B vaccination is given the age of 12yr, and HiB vaccination is in the program since 2003. Other available vaccines are against Hep A, varicella, pneumococcus and Influenza. All CF patients (100%) had vaccines following the national program, but they were behind the schedule for about 4 mo. 40% had HiB vaccination (the vaccine is available for 4 years). Immunization against Hep B is relatively low, because it is given at school age. No child was given Hep A vaccine. Only one patient was vaccinated against varicella and one against penumococcus. 70-86% of children had influenza immunization, 21 of them both in 2002 & 2003. Analyzing their medical charts 2 years prior to influenza immunization and in the last 2 years, a 25% decline in the incidence of respiratory infection was observed during the winter period (November-March). Conclusion: The coverage of the national immunization program is100%, although vaccination is often delayed due to frequent hospitalization. However, immunization strategies should be modified for the CF population, especially for hepatitis. Hep B should be given in infancy and Hep A vaccination should also be considered, because of frequent (evident or subclinical) liver disease. Therefore, fatal hepatitis is more likely to occur. In CF patients vaccinated against influenza, a significant decrease in respiratory exacerbations has been observed during winter in comparison to the pre-vaccination stage.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0108286
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Tamara Voskresensky-Baričić
(autor)
Dorian Tješić-Drinković
(autor)
Ana Votava-Raić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica